Sarina Ailawadi, Jennifer Elizabeth Murphy, Michael H. Storandt, Rohit Rao, Amit Mahipal. "Comparative outcomes of first-line atezolizumab plus bevacizumab (A+B) and durvalumab plus tremelimumab (D+T) in hepatocellular carcinoma (HCC).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.4163